New Strong Buy Stocks Instant

: Currently holds a unanimous Strong Buy rating from top analysts. Bank of America analysts point to a price target of $42 , representing approximately 37% upside, supported by a robust generics pipeline and upcoming FDA catalysts.

: Upgraded by Goldman Sachs and Oppenheimer after a record Q2 earnings beat. Analysts have set price targets as high as $297 , citing its dominant position in AI-driven electronic components. new strong buy stocks

: Labeled a "biotech breakout" by Citigroup with a maximum 1-year forecast of $242 , implying a potential 89% upside . : Currently holds a unanimous Strong Buy rating

: Labeled a top defensive choice due to its high-margin advertising business and 53 years of consecutive dividend growth. Analysts have set price targets as high as

As of late April 2026, several high-conviction "Strong Buy" ratings have emerged across the pharmaceutical, technology, and energy sectors, driven by record earnings beats and significant analyst price target upgrades. 🚀 Top Analyst Conviction Picks

Projected EPS growth of 313% with a low forward P/E of 6.13. 🛡️ Defensive & Value Strong Buys

: Recently upgraded to Outperform by Bernstein with a $358 target . The removal of regulatory "overhangs" has led to a consensus Strong Buy rating from 13 different analysts. 📊 Quantitative "Strong Buy" Additions (Zacks Rank #1)